Association between Cardiovascular Risk Assessment by SCORE2 and Diverticulosis: A Cross-Sectional Analysis.
SCORE2
cardiovascular risk
diverticulosis
metabolic syndrome
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
14 Aug 2024
14 Aug 2024
Historique:
received:
16
07
2024
revised:
11
08
2024
accepted:
13
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
The aim of this retrospective observational study was to examine the relationship between SCORE2 and the occurrence of colonic diverticula in a screening population without cardiovascular or gastrointestinal symptoms. SCORE2, recognized and supported by the European Society of Cardiology for cardiovascular risk assessment, served as the primary metric for the analysis in this investigation. We studied 3935 asymptomatic individuals undergoing screening colonoscopy. SCORE2 was calculated for each participant and categorized into three groups based on the following projected 10-year cardiovascular disease risk: SCORE2 0-4.9%, SCORE2 5-9.9%, and SCORE2 ≥ 10%. Logistic regression was used to assess the relationship between SCORE2 and diverticulosis. SCORE2 was associated with the presence of diverticulosis (OR 1.09, 95%CI 1.07-1.10; A higher SCORE2 was found to be a suitable screening parameter for diverticular disease. This suggests a potential link between cardiovascular risk factors and colon diverticula development, warranting further research on whether optimizing cardiovascular risk factors could positively influence diverticular disease.
Sections du résumé
BACKGROUND
BACKGROUND
The aim of this retrospective observational study was to examine the relationship between SCORE2 and the occurrence of colonic diverticula in a screening population without cardiovascular or gastrointestinal symptoms. SCORE2, recognized and supported by the European Society of Cardiology for cardiovascular risk assessment, served as the primary metric for the analysis in this investigation.
METHODS
METHODS
We studied 3935 asymptomatic individuals undergoing screening colonoscopy. SCORE2 was calculated for each participant and categorized into three groups based on the following projected 10-year cardiovascular disease risk: SCORE2 0-4.9%, SCORE2 5-9.9%, and SCORE2 ≥ 10%. Logistic regression was used to assess the relationship between SCORE2 and diverticulosis.
RESULTS
RESULTS
SCORE2 was associated with the presence of diverticulosis (OR 1.09, 95%CI 1.07-1.10;
CONCLUSIONS
CONCLUSIONS
A higher SCORE2 was found to be a suitable screening parameter for diverticular disease. This suggests a potential link between cardiovascular risk factors and colon diverticula development, warranting further research on whether optimizing cardiovascular risk factors could positively influence diverticular disease.
Identifiants
pubmed: 39202053
pii: jpm14080862
doi: 10.3390/jpm14080862
pmc: PMC11355319
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Clin Interv Aging. 2023 Aug 17;18:1373-1395
pubmed: 37609042
Eur Heart J. 2022 Feb 22;43(8):716-799
pubmed: 35016208
Eur J Gastroenterol Hepatol. 2020 Sep;32(9):1123-1129
pubmed: 32483087
Circulation. 2009 Oct 20;120(16):1640-5
pubmed: 19805654
Gut. 2019 May;68(5):854-865
pubmed: 30661054
Dig Dis. 2012;30(1):35-45
pubmed: 22572683
Gastroenterology. 2022 Feb;162(2):621-644
pubmed: 34678215
Dig Dis Sci. 2023 Mar;68(3):902-912
pubmed: 35695973
Eur Heart J. 2018 Sep 1;39(33):3021-3104
pubmed: 30165516
Mediators Inflamm. 2019 Mar 14;2019:8328490
pubmed: 31001067
Gastroenterology. 2021 Feb;160(3):906-911.e1
pubmed: 33279517
Dig Dis Sci. 2022 Apr;67(4):1337-1344
pubmed: 33770332
Eur Heart J. 2021 Jul 1;42(25):2439-2454
pubmed: 34120177
Korean J Gastroenterol. 2019 Sep 25;74(3):142-148
pubmed: 31554029
J Clin Gastroenterol. 2008 Nov-Dec;42(10):1137-8
pubmed: 18936652
N C Med J. 2016 May-Jun;77(3):220-2
pubmed: 27154895
Eur Radiol. 2019 Mar;29(3):1094-1103
pubmed: 30151643
J Pers Med. 2022 May 23;12(5):
pubmed: 35629269
Colorectal Dis. 2020 Sep;22 Suppl 2:5-28
pubmed: 32638537
Clin Gastroenterol Hepatol. 2013 Dec;11(12):1609-13
pubmed: 23856358
Am J Prev Cardiol. 2020 Nov 21;4:100130
pubmed: 34327481
Inflamm Intest Dis. 2018 Dec;3(2):69-74
pubmed: 30733950
Circulation. 2023 Feb 21;147(8):e93-e621
pubmed: 36695182
Endoscopy. 2016 Sep;48(9):843-64
pubmed: 27548885
Front Microbiol. 2015 Jun 30;6:671
pubmed: 26175728
Nat Rev Dis Primers. 2020 Mar 26;6(1):20
pubmed: 32218442
Ann Surg. 2009 Feb;249(2):210-7
pubmed: 19212172
Clin Gastroenterol Hepatol. 2016 Jul;14(7):980-985.e1
pubmed: 26872402
Acta Biomed. 2018 Dec 17;89(9-S):107-112
pubmed: 30561403
Gastroenterology. 2015 Dec;149(7):1944-9
pubmed: 26453777
Clin Gastroenterol Hepatol. 2018 Jun;16(6):884-891.e1
pubmed: 28603053
Int J Colorectal Dis. 2023 Sep 19;38(1):236
pubmed: 37725283
Adv Clin Exp Med. 2019 Dec;28(12):1615-1620
pubmed: 31025557
Nature. 2011 Apr 7;472(7341):57-63
pubmed: 21475195
Clin Colon Rectal Surg. 2018 Jul;31(4):209-213
pubmed: 29942208
Turk J Gastroenterol. 2014 Apr;25(2):192-7
pubmed: 25003681
J Surg Res. 2022 Dec;280:348-354
pubmed: 36037611
Clin Gastroenterol Hepatol. 2014 Oct;12(10):1695-701.e1
pubmed: 24316104